Joseph R. Tamayo | Vice President of Operations, Regulatory Affairs, Quality Assurance and Clinical Affairs (Consultant)

Joseph Tamayo has over 20 years of experience in the medical device industry. He specializes in regulatory and quality programs for hybrid or combination technology products. Prior to Osseon, Mr. Tamayo headed the Regulatory and Quality organizations for Medlogics Device Corporation (pre-IPO), a start-up developing drug eluting coronary stents, and Bioheart Incorporated (IPO), a biotech company involved in autologous cell therapies for congestive heart failure. He has held regulatory management positions at Cerus Corporation (IPO) and Arterial Vascular Engineering, Inc. (acquired by Medtronic, Inc). Mr. Tamayo received his Bachelor of Science Degree in Biological Sciences from Loyola Marymount University.